RTW Biotech Opportunities Ltd RTWFF
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -61.42% | 11.14% | 322.16% | 422.09% | 580.81% |
| Total Revenue | -61.42% | 11.14% | 322.16% | 422.09% | 580.81% |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -61.42% | 11.14% | 322.16% | 422.09% | 580.81% |
| SG&A Expenses | 5.15% | 6.22% | 7.39% | 22.84% | 43.18% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 8.06% | 10.21% | 12.58% | 27.43% | 47.16% |
| Operating Income | -104.71% | 12.49% | 625.92% | 633.31% | 640.64% |
| Income Before Tax | 592.69% | 1,303.31% | 617.36% | -10.48% | -167.67% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 592.69% | 1,303.31% | 617.36% | -10.48% | -167.67% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 592.69% | 1,303.31% | 617.36% | -10.48% | -167.67% |
| EBIT | -104.71% | 12.49% | 625.92% | 633.31% | 640.64% |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | 605.34% | 1,327.71% | 639.29% | -20.53% | -155.84% |
| Normalized Basic EPS | 877.91% | 383.90% | 96.83% | -18.46% | -120.05% |
| EPS Diluted | 605.34% | 1,327.71% | 639.29% | -20.53% | -155.84% |
| Normalized Diluted EPS | 877.91% | 383.90% | 96.83% | -18.46% | -120.05% |
| Average Basic Shares Outstanding | -2.55% | -2.39% | -2.23% | 8.58% | 21.86% |
| Average Diluted Shares Outstanding | -2.55% | -2.39% | -2.23% | 8.58% | 21.86% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |